Inhibrx Biosciences Inc. (INBX)

13.50

0.25 (1.89%)

At close: Mar 03, 2025, 3:59 PM

13.58

0.59%

After-hours: Mar 03, 2025, 04:00 PM EST

Inhibrx Biosciences Cash Flow Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16
Net Income	-239.73M	-145.23M	-81.77M	-76.12M	-51.4M	-31.02M	-22.08M	-8.27M
Depreciation & Amortization	1.19M	1.23M	1.2M	1.02M	1.16M	676K	399K	253K
Stock-Based Compensation	24.85M	17.79M	15.05M	5.02M	3.97M	2.48M	1.18M	552K
Other Working Capital	13.76M	3.74M	-1.67M	-5.61M	8.94M	556K	-556K	-6.35M
Other Non-Cash Items	5.03M	5.09M	2.73M	11.56M	9.61M	522K	746K	-3.37M
Deferred Income Tax	n/a	n/a	-9K	-2.14M	1.08M	n/a	n/a	n/a
Change in Working Capital	15.35M	3.16M	-17.52M	12.69M	3.48M	4.25M	999K	-6.28M
Operating Cash Flow	-193.31M	-115.3M	-80.32M	-47.97M	-32.08M	-23.09M	-18.75M	-18.11M
Capital Expenditures	-4.59M	-686K	-864K	-1.36M	-1.81M	-1.43M	-1.34M	-215K
Acquisitions	n/a	n/a	55K	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	55K	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	-4.59M	-686K	-809K	-1.36M	-1.81M	-1.43M	-1.34M	-215K
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	-828K	-1.38M	n/a
Other Financial Acitivies	201.96M	128.81M	83.77M	166.46M	43.33M	13.98M	14.91M	28.77M
Financial Cash Flow	201.96M	258.55M	83.77M	166.46M	43.33M	13.15M	13.54M	28.77M
Net Cash Flow	4.06M	142.56M	2.64M	117.12M	9.44M	-11.37M	-6.55M	10.45M
Free Cash Flow	-197.9M	-115.99M	-81.19M	-49.33M	-33.89M	-24.52M	-20.09M	-18.32M